Evidence map›Paper›PMID 24773432›Full record

ArticleBehavioral neuroscience2014

Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.

Laura M Grant, Franziska Richter, Julie E Miller, Stephanie A White, Cynthia M Fox, Chunni Zhu, Marie-Francoise Chesselet, Michelle R Ciucci

Open access · greenAbstract read
In one paragraph

Article in Behavioral neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Reduced cerebral blood flow in anJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Laura M GrantDepartment of Surgery, Division of Otolaryngology- Head & Neck Surgery, University of Wisconsin.
Franziska RichterDepartment of Neurology, David Geffen School of Medicine at UCLA.
Julie E MillerDepartment of Integrative Biology and Physiology, UCLA.
Stephanie A WhiteDepartment of Integrative Biology and Physiology, UCLA.
Cynthia M FoxNational Center for Voice and Speech, University of Colorado.
Chunni ZhuDepartment of Neurology, David Geffen School of Medicine at UCLA.
Marie-Francoise ChesseletDepartment of Neurology, David Geffen School of Medicine at UCLA.
Michelle R CiucciDepartment of Surgery, Division of Otolaryngology-Head & Neck Surgery, University of Wisconsin.
University of California, Los Angeles · USLaboratoire d’immunologie intégrative du cancer · FRUniversity of Wisconsin–Madison · USDenver Center for the Performing Arts · US

Funding

UCLA CENTER FOR THE STUDY OF PARKINSON'S DISEASEP50NS038367 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHESSELET, MARIE-FRANCOISE S · 1999 to 2011
$15.3M
University of Wisconsin Voice Research Training Program (T32)T32DC009401 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI Susan Lynn Thibeault · 2009 to 2026
$6.3M
Neuroendocrinology, Sex Differences, and ReproductionT32HD007228 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARNOLD, ARTHUR P · 1985 to 2015
$3.9M
Formation and Function of Circuitry for Vocal LearningR01MH070712 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WHITE, STEPHANIE ANN · 2005 to 2017
$3.1M
P30 Application "Voice and Swallow Neuroscience Research Core"P30DC010754 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI CONNOR, NADINE P · 2009 to 2010
$764k
NICHD NIH HHS T32 HD007228NIDCD NIH HHS P30 DC 010754NIDCD NIH HHS P30 DC010754NIDCD NIH HHS T32 DC009401NIMH NIH HHS R01 MH070712NINDS NIH HHS NS-P50 NS38367NINDS NIH HHS P50 NS038367
6 · The paper itself

Abstract

Communication and swallowing deficits are common in Parkinson's disease (PD). Evidence indicates that voice and speech dysfunction manifest early, prior to motor deficits typically associated with striatal dopamine loss. Unlike deficits in the extremities, cranial sensorimotor deficits are refractory to standard dopamine-related pharmacological and surgical interventions, thus the mechanisms underlying vocal deficits are unclear. Although neurotoxin models have provided some insight, they typically model nigrostriatal dopamine depletion and are therefore limited. Widespread alpha-synuclein (aSyn) pathology is common to familial and sporadic PD, and transgenic mouse models based on aSyn overexpression present a unique opportunity to explore vocalization deficits in relation to extrastriatal, nondopaminergic pathologies. Specifically, mice overexpressing human wild-type aSyn under a broad neuronal promoter (Thy1-aSyn) present early, progressive motor and nonmotor deficits starting at 2-3 months, followed by parkinsonism with dopamine loss at 14 months. We recorded ultrasonic vocalizations from Thy1-aSyn mice and wild-type (WT) controls at 2-3, 6-7, and 9 months. Thy1-aSyn mice demonstrated early, progressive vocalization deficits compared with WT. Duration and intensity of calls were significantly reduced and call profile was altered in the Thy1-aSyn mice, particularly at 2-3 months. Call rate trended toward a more drastic decrease with age in the Thy1-aSyn mice compared with WT. Alpha-synuclein pathology is present in the periaqueductal gray and may underlie the manifestation of vocalization deficits. These results indicate that aSyn overexpression can induce vocalization deficits at an early age in mice and provides a new model for studying the mechanisms underlying cranial sensorimotor deficits and treatment interventions for PD.

Indexed as

alpha-SynucleinAnimalsDisease Models, AnimalFemaleHumansMaleMiceMice, Inbred C57BLMice, TransgenicParkinson DiseaseVocalization, Animalalpha-SynucleinSNCA protein, human

Identifiers

PMID24773432
PMCPMC4079049
OpenAlexW2058848526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.